Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. Atallah E, Grove JI, Crooks C, Burden-Teh E, et al. J Hepatol 2023;78:989-997.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Atallah E, Grove JI, Crooks C, Burden-Teh E, et al. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J Hepatol 2023;78:989-997.
PMID: 36702175